Home
OrbiMed

OrbiMed Market Share Analysis for May 2026

OrbiMed is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered one of the world's largest dedicated healthcare investment firms.

Finance > Investing

Domainorbimed.com

Year Founded1989

Employees51 - 200

Annual Revenue$25M - $50M

OrbiMed

OrbiMed (including company regionals)

orbimed.com

See more website traffic and engagement information

OrbiMed Revenue up to May 2026 is 25M - 50M

revenue generated by OrbiMed top domains

OrbiMed top domains revenue over 3 years

Revenue for OrbiMed top domains

orbimed.com25M - 50M

See more with Sales Intelligence

Total visits to OrbiMed's top domains

Understand OrbiMed market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

orbimed.com25.4K

See more with Sales Intelligence

Avg. visit duration in OrbiMed's top domains

Analyze OrbiMed engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

orbimed.com00:02:23

See more with Sales Intelligence

Avg. pageviews on OrbiMed's top domains

See how OrbiMed keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

orbimed.com4.00

See more with Sales Intelligence

OrbiMed top competitors by domain

Top similar sites in May 2026, ranked by their affinity

aurelius-group.comCompany NameAureliusEmployees> 10001HQUnited Kingdom, LondonAnnual revenue> $1BTotal visits32KFinance > Investing

Top technologies used by OrbiMed

These are the website technologies, by industry, used by OrbiMed top domains

Widget (3)

Twemoji

Advertising (2)

Google Remarketing

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from OrbiMed

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOrbiMed invested into Windward Bio AG $165M in crossover financing on May 4th '26.Windward Bio, a private, clinical-stage biotechnology company committed to improving outcomes for people living with serious immunological diseases, today announced an upsized $165 million crossover financing led by OrbiMed, with participation from existing Series A investors including Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners.

NewsOrbiMed invests into SpectronRx $85M in financing.SpectronRx, a diagnostic and therapeutic radiopharmaceutical developer and manufacturer specializing in radiopharmaceutical contract development, manufacturing, and isotope production, has raised $85 million in financing from OrbiMed.

NewsOrbiMed invested into Thrombolex, Inc. $50M in Series A on Mar 16th '26.New Britain, PA, March 16, 2026 - Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases, announced the closing of a $50 million Series A equity financing led by OrbiMed, with strong support from current investors and co-founders.